FDA Approved: TIGLUTIK — Original Application (EDW PHARMA, INC)

View source ↗

Summary

FDA approved Tiglutik (riluzole) under an Original Application from Edw Pharma, Inc., adding a riluzole product to treat amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• TIGLUTIK (RILUZOLE)

Snippet

ORIG AP for TIGLUTIK (RILUZOLE)